Literature DB >> 11874187

An activating mutation of the thyrotropin receptor gene in hereditary non-autoimmune hyperthyroidism.

Yung-Seng Lee1, LarryKokSeng Poh, Kah-Yin Loke.   

Abstract

The thyroid stimulating hormone (TSH) receptor gene displays a diverse spectrum of activating and inactivating mutations. We report a germline activating mutation M463V of the TSH receptor gene in two siblings with hereditary non-autoimmune hyperthyroidism. The onset of disease in the affected members of the pedigree occurred during childhood or adolescence. The significance of diagnosing activating TSHR mutations lies in therapeutic management and genetic counseling; thyroid ablation is advocated as first line treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11874187     DOI: 10.1515/jpem.2002.15.2.211

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  10 in total

1.  Subclinical nonautoimmune hyperthyroidism in a family segregates with a thyrotropin receptor mutation with weakly increased constitutive activity.

Authors:  Eijun Nishihara; Chun-Rong Chen; Takuya Higashiyama; Yumiko Mizutori-Sasai; Mitsuru Ito; Sumihisa Kubota; Nobuyuki Amino; Akira Miyauchi; Basil Rapoport
Journal:  Thyroid       Date:  2010-10-07       Impact factor: 6.568

2.  Novel germline mutation (Leu512Met) in the thyrotropin receptor gene (TSHR) leading to sporadic non-autoimmune hyperthyroidism.

Authors:  Stephanie A Roberts; Jennifer E Moon; Andrew Dauber; Jessica R Smith
Journal:  J Pediatr Endocrinol Metab       Date:  2017-03-01       Impact factor: 1.634

3.  2012 European thyroid association guidelines for the management of familial and persistent sporadic non-autoimmune hyperthyroidism caused by thyroid-stimulating hormone receptor germline mutations.

Authors:  R Paschke; M Niedziela; B Vaidya; L Persani; B Rapoport; J Leclere
Journal:  Eur Thyroid J       Date:  2012-10-04

4.  Detection of combined genomic variants in a Jordanian family with familial non-autoimmune hyperthyroidism.

Authors:  Said I Ismail; Ismail S Mahmoud; Mahmoud Al-Ardah; Amid Abdelnour; Nidal A Younes
Journal:  J Genet       Date:  2009-08       Impact factor: 1.166

5.  Congenital neonatal hyperthyroidism caused by germline mutations in the TSH receptor gene.

Authors:  Jeremy Chester; Deborah Rotenstein; Usanee Ringkananont; Guy Steuer; Beatrice Carlin; Lindsay Stewart; Helmut Grasberger; Samuel Refetoff
Journal:  J Pediatr Endocrinol Metab       Date:  2008-05       Impact factor: 1.634

6.  A somatic gain-of-function mutation in the thyrotropin receptor gene producing a toxic adenoma in an infant.

Authors:  Brenda Kohn; Helmut Grasberger; Leslie L Lam; Alfonso Massimiliano Ferrara; Samuel Refetoff
Journal:  Thyroid       Date:  2009-02       Impact factor: 6.568

7.  A CASE OF FAMILIAL NONAUTOIMMUNE HYPERTHYROIDISM DURING PREGNANCY.

Authors:  Yuka Okazaki; Naoko Arata; Nagayoshi Umehara; Taisuke Yamauchi; Junnichi Tajiri; Akira Hishinuma; Takahiko Kogai; Takashi Idegami; Atsuko Murashima; Haruhiko Sago
Journal:  AACE Clin Case Rep       Date:  2020-01-22

8.  Constitutive activation of the thyroid-stimulating hormone receptor (TSHR) by mutating Ile691 in the cytoplasmic tail segment.

Authors:  Zheng Liu; Feiyue Fan; Xiangjun Xiao; Yuanming Sun
Journal:  PLoS One       Date:  2011-01-21       Impact factor: 3.240

9.  Severe thyrotoxicosis in an infant revealing familial nonautoimmune hyperthyroidism with a novel (C672W) stimulating thyrotropin receptor germline mutation.

Authors:  Isabelle Oliver-Petit; Frédérique Savagner; Solange Grunenwald; Magaly Vialon; Thomas Edouard; Philippe Caron
Journal:  Clin Case Rep       Date:  2017-10-25

10.  Central TSH Dysregulation in a Patient with Familial Non-Autoimmune Autosomal Dominant Hyperthyroidism Due to a Novel Thyroid-Stimulating Hormone Receptor Disease-Causing Variant.

Authors:  Jasna Suput Omladic; Maja Pajek; Urh Groselj; Katarina Trebusak Podkrajsek; Magdalena Avbelj Stefanija; Mojca Zerjav Tansek; Primoz Kotnik; Tadej Battelino; Darja Smigoc Schweiger
Journal:  Medicina (Kaunas)       Date:  2021-02-25       Impact factor: 2.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.